Lance Converse

Chief Innovation Officer

Biography

Lance Converse has over 30 years of experience founding and building highly successful companies in the pharmaceutical services, eClinical technology, and drug development sector.

Lance serves as the Chief Innovation Officer of WCG, supporting its innovation and M&A activities. Prior to starting ePharmaSolutions, which was acquired by WCG, Converse was founder and CEO of Acurian, a leading patient recruitment firm; founder and CEO of ReSearch Pharmaceutical Services (RPS), a leading clinical outsourcing firm which later sold to PRA, and co-founder of Diasome Pharmaceuticals.